Skip to content

The functional added-value of microprocessor-controlled knee joint for amputees over the age of 65, a pilot study.

The functional added-value of microprocessor-controlled knee joint for amputees over the age of 65, a pilot study. - Kenevo, a pilot study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42992
Enrollment
10
Registered
2016-11-03
Start date
2017-02-16
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amputatie van been amputation of upper leg transfemoral amputation

Interventions

A microprocessor-controlled prosthetic knee joint, called Kenevo, specifically developed for elderly amputees. IMPORTANT This pilot study is a feasibility study to acquire initial data to be used i

Sponsors

Adelante
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: o Age 65 years and older. o Unilateral above-knee amputation or knee disarticulation. o Comfortable walking speed between 0.2-0.8 m/s o Wearing prosthesis. o Have completed an active rehabilitation program in the past o Limited activity in and around the house.

Exclusion criteria

Exclusion criteria: o Additional severe orthopaedic, rheumatologic or neurological impairments that may impede gait-related performance. o Severe perceptual or cognitive impairments. o Lack of understanding the Dutch language (in view of e.g. questionnaires used).

Design outcomes

Primary

MeasureTime frame
Level of independence in everyday life activities, both actual and perceived. This will be measured using the Assessment of Daily Activity Performance in Transfemoral amputee test (ADAPT) and the Locomotor Capabilities Index (LCI).

Secondary

MeasureTime frame
Needs and Provision Complexity Scale (NPCS), Prosthetic Limb Users Survey of Mobility (PLUS-M), Activity-specific Balance Confidence Scale (ABC), Falls Efficacy Scale International (FES) and 2 minute walk test (2MWT).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)